| 01 Sept, 05:59 pm | other | 1 | Caplin One Labs Limited, a subsidiary of Caplin Point Laboratories Limited, received GMP compliance certification from INVIMA. | nse |
| 01 Sept, 05:43 pm | procedural | 0 | NSE observes a significant volume increase in Caplin Point Laboratories Limited and has written to the company for information; response is awaited. | nse |
| 21 Aug, 07:12 pm | — | … | Caplin Point Laboratories Limited has informed the Exchange regarding 'Completion of Unannounced US FDA Inspection at the facility of Caplin Steriles Limited (Company s Subsidiary)'. | nse |
| 21 Aug, 07:07 pm | — | … | Caplin Point Laboratories Ltd - 524742 - General Updates | bse |
| 19 Aug, 06:09 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 19 Aug, 06:02 pm | — | … | Caplin Point Laboratories Limited has informed the Exchange about Transcript | nse |
| 12 Aug, 06:46 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 12 Aug, 06:44 pm | — | … | Caplin Point Laboratories Limited has informed the Exchange about Link of Recording | nse |
| 12 Aug, 03:10 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 12 Aug, 03:06 pm | — | … | Caplin Point Laboratories Limited has informed the Exchange about Investor Presentation | nse |
| 12 Aug, 03:00 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 12 Aug, 02:58 pm | — | … | Caplin Point Laboratories Limited has informed the Exchange regarding Change in Director(s) of the company. | nse |
| 12 Aug, 01:41 pm | — | … | Caplin Point Laboratories Limited has informed the Exchange that Board of Directors at its meeting held on August 12, 2026, recommended Final Dividend of Rs. 4 per equity share. | nse |
| 12 Aug, 01:41 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Results For Quarter Ended June 30, 2026 | bse |
| 12 Aug, 01:37 pm | — | … | Caplin Point Laboratories Limited has informed the Exchange that Record date for the purpose of Dividend is 18-Sep-2026. | nse |
| 12 Aug, 01:36 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Corporate Action-Board approves Dividend | bse |
| 12 Aug, 01:32 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Board Meeting Outcome for Meeting Held On August 12, 2026 | bse |
| 12 Aug, 01:31 pm | — | … | Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026. | nse |
| 29 Jul, 04:39 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Board Meeting Intimation for Approval Of Financial Results And Recommendation Of Final Dividend, If Any. | bse |
| 16 Jun, 06:25 pm | — | … | Caplin Point Laboratories Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. | nse |
| 29 May, 05:16 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Compliances-Reg.24(A)-Annual Secretarial Compliance | bse |
| 21 May, 06:26 pm | — | … | Caplin Point Laboratories Limited has informed the Exchange about Transcript | nse |
| 21 May, 06:21 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 14 May, 07:38 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 14 May, 07:33 pm | — | … | Caplin Point Laboratories Limited has informed the Exchange about Link of Recording | nse |
| 14 May, 07:09 pm | — | … | Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated May 14, 2026, titled "Receipt of final approval by our subsidiary, Caplin Steriles Limited, from the USFDA for Foscarnet Sodium Injection.". | nse |
| 14 May, 07:00 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 14 May, 01:28 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Corporate Action-Board approves Dividend | bse |
| 14 May, 01:24 pm | — | … | Caplin Point Laboratories Limited has informed the Exchange that Record date for the purpose of Dividend is 30-May-2026. | nse |
| 14 May, 01:23 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Financial Results For The Quarter And Year Ended March 31, 2026 | bse |
| 14 May, 01:23 pm | — | … | Caplin Point Laboratories Limited has informed the Exchange that Board of Directors at its meeting held on May 14, 2026, declared Interim Dividend of Rs. 4 per equity share. | nse |
| 14 May, 01:16 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Board Meeting Outcome for For Meeting Held On May 14, 2026 | bse |
| 14 May, 01:16 pm | — | … | Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. | nse |
| 07 May, 04:06 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Board Meeting Intimation for Approval Of Financial Results And Declaration Of Interim Dividend, If Any, Approved By The Board. | bse |
| 05 May, 12:43 pm | — | … | Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated May 05, 2026, titled "Receipt of final approval by our Subsidiary, Caplin Steriles Limited, from the USFDA for Calcium Gluconate Injection USP". | nse |
| 05 May, 12:34 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 13 Mar, 12:03 pm | — | … | Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated March 13, 2026, titled "Receipt of final approval by our Subsidiary, Caplin Steriles Limited, from the USFDA for the Potassium Phosphates Injection USP". | nse |
| 13 Mar, 11:52 am | — | … | Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 03 Mar, 06:47 pm | — | … | Caplin Point Laboratories Limited has informed the Exchange regarding Cessation of Dr. C K Gariyali as Non- Executive Independent Director of the company w.e.f. March 03, 2026. | nse |
| 03 Mar, 06:40 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Cessation | bse |
| 28 Feb, 11:57 am | — | … | Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated February 28, 2026, titled "Receipt of final approval by our Subsidiary, Caplin Steriles Limited, from the USFDA for the Desmopressin Acetate Injection USP". | nse |
| 28 Feb, 11:45 am | — | … | Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 24 Feb, 12:40 pm | — | … | Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated February 24, 2026, titled "Receipt of final approval by our Subsidiary, Caplin Steriles Limited, from the USFDA for the Sodium Phosphates Injection USP " | nse |
| 24 Feb, 12:17 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 11 Feb, 09:39 pm | — | … | Caplin Point Laboratories Limited has informed the Exchange about Transcript | nse |
| 11 Feb, 09:24 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 05 Feb, 09:35 pm | — | … | Caplin Point Laboratories Limited has informed the Exchange about Link of Recording | nse |
| 05 Feb, 09:29 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 05 Feb, 02:40 pm | — | … | Caplin Point Laboratories Limited has informed the Exchange about Investor Presentation | nse |
| 05 Feb, 02:22 pm | — | … | Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |